Structure-Based Screening of Potential Triterpenoids for Anti-Viral Activity Against SARS-CoV-2 and Related Coronaviruses
Triterpenoids possess valuable medicinal properties ranging from anti-microbial to anti-cancer. Some of them were known for their activity against HIV, Ebola and Influenza viruses. In this study, 108 triterpenoids were screened for its potential usage as anti-viral drug against SARS-CoV-2, MERS and SARS coronaviruses, using molecular docking calculation against their main proteases (Mpro) and ADME based drug-likeliness parameters..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
chemRxiv.org - (2021) vom: 18. Nov. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jeyaraj, Vijaya sundar [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
doi: |
10.26434/chemrxiv.12746558 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XCH018475760 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XCH018475760 | ||
003 | DE-627 | ||
005 | 20230429142642.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200803s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.26434/chemrxiv.12746558 |2 doi | |
035 | |a (DE-627)XCH018475760 | ||
035 | |a (chemrXiv)10.26434/chemrxiv.12746558 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jeyaraj, Vijaya sundar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Structure-Based Screening of Potential Triterpenoids for Anti-Viral Activity Against SARS-CoV-2 and Related Coronaviruses |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Triterpenoids possess valuable medicinal properties ranging from anti-microbial to anti-cancer. Some of them were known for their activity against HIV, Ebola and Influenza viruses. In this study, 108 triterpenoids were screened for its potential usage as anti-viral drug against SARS-CoV-2, MERS and SARS coronaviruses, using molecular docking calculation against their main proteases (Mpro) and ADME based drug-likeliness parameters. | ||
650 | 4 | |a Chemistry |7 (dpeaa)DE-84 | |
650 | 4 | |a 540 |7 (dpeaa)DE-84 | |
700 | 1 | |a Aarthy, Thiagarayaselvam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t chemRxiv.org |g (2021) vom: 18. Nov. |
773 | 1 | 8 | |g year:2021 |g day:18 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.26434/chemrxiv.12746558 |z kostenfrei |3 Volltext |
912 | |a GBV_XCH | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2021 |b 18 |c 11 |